InsidersTradesSigma
Total declarations
Companies
▲ Purchases (8 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
8
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Venkatesan Jay, Directeur. Director active across 5 companies, notably ALPINE IMMUNE SCIENCES, INC.. Cumulatively, 16 reports have been published. Breakdown: 8 buys · 2 sells. Total volume traded: €6.9m. Activity tracked since 17 September 2021. The latest transaction was disclosed on 31 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations16 total
7,553 shares@ US$1.94100.0% of flowCommon StockSEC:0001413350-26-000002:0
50,000 shares@ US$0.01100.0% of flowCommon StockSEC:0001601485-24-000105:0
20,063 shares@ US$0.45100.0% of flowCommon StockSEC:0001626199-22-000052:0
11,313 shares@ US$1.24660.4% of flowCommon StockSEC:0001601485-22-000043:0
Ideal exit: 19 Feb 2023 (T+270)
396,329 shares@ US$6.4359.1% of flowCommon StockSEC:0001601485-22-000045:0
50,000 shares@ US$1.231.6% of flowCommon StockSEC:0001601485-22-000039:0
Ideal exit: 14 Feb 2023 (T+270)
66,907 shares@ US$2.54864.2% of flowCommon StockSEC:0001601485-21-000095:0
Ideal exit: 23 Sept 2022 (T+270)
66,907 shares@ US$2.54864.2% of flowCommon StockSEC:0001601485-21-000095
Ideal exit: 23 Sept 2022 (T+270)
3,527 shares@ US$2.54490.2% of flowCommon StockSEC:0001601485-21-000093
Ideal exit: 16 Sept 2022 (T+270)
3,527 shares@ US$2.54490.2% of flowCommon StockSEC:0001601485-21-000093:0
Ideal exit: 16 Sept 2022 (T+270)
27,883 shares@ US$2.54611.8% of flowCommon StockSEC:0001601485-21-000089
Ideal exit: 12 Sept 2022 (T+270)
27,883 shares@ US$2.54611.8% of flowCommon StockSEC:0001601485-21-000089:0
Ideal exit: 12 Sept 2022 (T+270)
41,091 shares@ US$13.7813.3% of flowCommon StockSEC:0001601485-21-000087
41,091 shares@ US$13.7813.3% of flowCommon StockSEC:0001601485-21-000087:0
400,000 shares@ US$9.4050.0% of flowCommon StockSEC:0001626199-21-000113:0
400,000 shares@ US$9.4050.0% of flowCommon StockSEC:0001626199-21-000113
16 of 16 declarations
About Venkatesan Jay
Jay Venkatesan is a Director at Alpine Immune Sciences, Inc. and Angion Biomedica Corp. He brings his expertise to the board, contributing to the strategy and direction of both companies.
